For advocates of women’s reproductive health, it’s been pretty much all doom and gloom since last summer when the Supreme Court’s Dobbs decision overturned Roe v. Wade, ending a nearly 50-year US constitutional right to abortion.
One of the few moments of hope for women’s health advocates came in January, when the US Food and Drug Administration opened a new channel for medication abortion by giving pharmacies the greenlight to dispense the abortion pill mifepristone. A day later, Walgreens Boots Alliance Inc. was the first of the big pharmacy owners to say it would apply for certification under the program. CVS Health Corp. and Rite Aid ...
